Abstract
Campylobacter jejuni is a major food-borne zoonotic pathogen, responsible for a large proportion of bacterial gastroenteritis cases, as well as Guillian-Barré and Miller-Fisher syndromes. During infection, tissue damage is mainly caused by bacteria invading epithelial cells and traversing the intestinal barrier. C. jejuni is able to enter the lamina propria and the bloodstream and may move into other organs, such as spleen, liver, or mesenteric lymph nodes. However, the involved molecular mechanisms are not fully understood. C. jejuni can transmigrate effectively across polarized intestinal epithelial cells mainly by the paracellular route using the serine protease high-temperature requirement A (HtrA). However, it appears that HtrA has a dual function, as it also acts as a chaperone, interacting with denatured or misfolded periplasmic proteins under stress conditions. Here, we review recent progress on the role of HtrA in C. jejuni pathogenesis. HtrA can be transported into the extracellular space and cleaves cell-to-cell junction factors, such as E-cadherin and probably others, disrupting the epithelial barrier and enabling paracellular transmigration of the bacteria. The secretion of HtrA is a newly discovered strategy also utilized by other pathogens. Thus, secreted HtrA proteases represent highly attractive targets for anti-bacterial treatment and may provide a suitable candidate for vaccine development.
Keywords: HtrA, C. jejuni proteases, E-cadherin, fibronectin, occludin, integrins, LOS, molecular pathogenesis, cellular invasion, signaling, TER, outer membrane vesicles (OMVs), tight junction, adherens junction, virulence
Introduction: The Lifestyle of C. jejuni
Foodborne illnesses are a major public health problem that have proven to be difficult to resolve, despite multiple and focussed efforts over the past 25 years. Diarrhoeal diseases are responsible for high rates of morbidity and mortality in developing nations, and are also frequent in industrialized countries [1–3]. It has been estimated that bacterial and viral infections of the gastrointestinal tract together kill approximately 2.2 million people annually worldwide, which has a large negative impact on public health and presents a serious burden to public health services [4–6]. Meanwhile, in a number of countries, Salmonella infections have decreased in the past decade, the decrease in infections caused by Campylobacter species has been less or absent, so that in some countries these infections are now more frequent than infections by Salmonella, pathogenic Escherichia, or other bacterial enteropathogens [7–9].
Campylobacter jejuni is a zoonotic pathogen [10]. These highly motile, spiral-shaped Gram-negative bacteria require microaerobic conditions and a temperature between 37 °C and 42 °C for growth. These conditions allow these bacteria to asymptomatically colonize the gastrointestinal tract of a wide range of wild and domestic birds and animals. The natural niche of C. jejuni is the avian intestine, and it is commonly present in poultry [11]. Consumption of contaminated (animal-derived) foods is a major means of transmission to humans, and food-borne campylobacteriosis cases account for 400–500 million cases annually [12], corresponding to estimated 33 million Disability Adjusted Life Years (DALYs) [3]. However, not all infections result in disease, and it is estimated that the majority of humans encounters with C. jejuni remain without symptoms [13], although prolonged asymptomatic colonisation is uncommon in developed countries. When disease occurs, it presents with symptoms ranging from mild, non-inflammatory, self-limiting diarrhea to severe inflammatory bloody diarrhea that may require hospitalization [14–17]. C. jejuni infection can also lead to potentially more severe sequelae, such as the Miller-Fisher or Guillain–Barré syndromes [10, 18, 19].
Multiple efforts to unravel the molecular mechanisms of C. jejuni virulence have identified a number of bacterial factors that have a role in the pathogenesis of this organism, but their exact activities and interplay with host factors are still poorly understood. In order to cause infection, C. jejuni enters the human gut via the oral route, where it can colonize the mucus layer of the small intestine or attach to intestinal epithelial cells [20]. Quorum sensing plays an important role in C. jejuni colonization as it can regulate the expression of multiple genes involved in virulence, toxin production, motility, chemotaxis, and biofilm formation, thus contributing to environmental adaptation [21]. Bacterial adhesion to and invasion into epithelial gastrointestinal cells are considered as a primary cause of tissue damage in humans [22]. In order to adhere to cells, the mucus layer has to be crossed, for which the highly motile bacteria are well equipped. Bacterial adhesion is then enabled by specific adhesins, which are exposed on the bacterial surface and bind to host cell receptors. Currently, at least seven different types of proteins have all been proposed to act as bacterial adhesins: Campylobacter adhesion to fibronectin (CadF) [23, 24], major outer membrane protein (MOMP) [25], periplasmic binding protein (PEB1) [26], P95 [27], jejuni lipoprotein A (JlpA) [28, 29], Campylobacter autotransporter protein A (CapA) [30], and fibronectin-like protein A (FlpA) [31, 32]. The contribution of each of these factors to pathogenesis is under much debate.
Following adhesion to epithelial cells, many strains of C. jejuni are able to enter cells, though in vitro determined levels of invasion can be lower than those obtained with strongly invasive organisms, such as Salmonella enterica or enteroinvasive Escherichia coli strains [33]. Using in vitro models of invasion, it was observed that non-motile C. jejuni mutants invade less efficiently [34], and since motility was shown to be required for invasion and translocation through cells [35], it is possible that the bacteria use motion force to propel themselves into the cells by means of their flagella. Alternatively, the flagellum may serve as a delivery device for virulence factors, which trigger host cell entry, as has been suggested for Campylobacter invasion antigens C [36] and D [37] (CiaC and CiaD). In order to reach deeper tissues, C. jejuni may not only pass the epithelial barrier by cellular invasion and escape, but also by paracellular translocation across tight junctions. The bacteria are surprisingly fast in doing so, at least in confluent cell layers in vitro [35]. The secretion of bacterial factors into host cells has been proposed as a further contribution to virulence [39], although classical type-III or type-IV secretion systems (T3SSs or T4SSs) are absent. Secreted effector proteins include Campylobacter invasion antigens (Cia) [40] and flagellar co-expressed determinant (Fed) proteins [41, 42]. Amongst the secreted proteins with a function in virulence of C. jejuni, the serine protease high-temperature requirement A (HtrA) can be added, which is involved in stress response, as well as in virulence [43].
Bacterial proteins need to be properly folded to maintain their function, but an array of stresses can cause denaturation and protein aggregation, which are deleterious to the cell. These malfunctioning proteins and their aggregates need to be removed, for which a cell uses specialized proteases. The serine proteases of the HtrA family degrade denatured proteins and in that way limit damage produced by a variety of stresses [44]. Their name reminds of their protective role in temperature stress, as they were first discovered in E. coli being responsible for a high temperature requirement phenotype [45]. A protease known as DegP in E. coli [46] turned out to be identical to HtrA, so that this bifunctional protein is now known by both names. Subsequently, DegQ and DegS were discovered in E. coli, which were similar in structure and function to DegP/HtrA [47]. A sequence alignment of DegP and DegQ revealed an amino acid identity of 60%. The main difference is the lack of 20 amino acids in the N-terminally positioned LA-Loop of DegQ. The LA-Loop for his part is important for the stabilization of the inactive hexameric conformation of DegP. It has been postulated that DegQ is able to compensate the lack of DegP [48]. In turn, other studies showed that DegP, DegQ, and DegS mutants might have the same phenotype, suggesting they have different roles. Additionally, the re-expression of DegQ or DegS did not replace function of DegP in a knockout mutant [47, 49]. Different studies indicate that DegP and DegQ have different roles in the bacterial periplasm and could not give the answer whether they share overlapping functions [50]. Campylobacter jejuni only contains one HtrA-type protein, which is a DegQ homolog, and although that name is used in Campylobacter genome annotations, we will refer to it as HtrA [38, 51] here. All known HtrA proteins combine a proteolytic functional domain with one or two peptide-binding domains displaying ATP-independent chaperone activity [44, 52]. As will be discussed in this review, the HtrA homolog of C. jejuni enhances adhesion, cellular invasion, and bacterial transmigration via the paracellular route and is also involved in stress tolerance. As such, it plays a pivoting role in the life cycle of this organism.
General Structure and Function of Bacterial HtrA Proteins
Tolerance to oxidative and heat stress is of key importance for every organism and includes the degradation of intracellular irreversibly misfolded proteins [53, 54]. Among others, HtrA proteases play an important role in these stress responses and can be found in both prokaryotes and eukaryotes including humans [44, 52, 55, 56]. HtrA undergoes oligomerization and conformational changes when encountering denatured proteins, which switches on its proteolytic activity. These oligomerization and configuration processes have been studied in detail for HtrA homologs from a number of organisms, such as Thermotoga maritima [57], E. coli [58, 59], Legionella pneumophila [60] and Helicobacter pylori [61]. Bacterial HtrAs are predominantly localized in the periplasm and de novo protein typically contains an N-terminal signal peptide that must be removed during transport across the inner membrane before the protein becomes active. Thus, the key role of HtrA may be to protect the cell against denatured proteins in the periplasm, whereas other proteases are responsible for protein maintenance in the cytosol.
The protease domain of HtrA contains a His–Asp–Ser catalytic triad (HDS), and this domain is followed by one or two PDZ (protein–protein interaction) domains, depending on the species and HtrA variant [62–64] (Figure 1A). Of the three E. coli HtrA homologues, most detailed insights are available for DegP, and since there are no fundamental differences with DegQ, we briefly review DegP here. It was shown that in the periplasm, DegP polymerizes into a hexamer (DegP6) that is enzymatically inactive. In this configuration, the proteolytic active site is hidden in a pouch within the hexamer structure, as reviewed more extensively elsewhere [65]. In the configuration of DegP6, the PDZ1 domain can be reached only by unfolded proteins. Binding of such denatured proteins to PDZ1 of DegP6 results in destabilization of the hexamer by rearrangements of the PDZ1 and PDZ2 domains. This facilitates the assembly of higher order oligomers DegP12 and DegP24, where the PDZ1 domain is now fixed to interact with a sensory loop of the protease domain, called L3. The loop rearranges and causes a remodelling of the active domain into its active state. PDZ1, the proteolytic site, and L3 are now able to bind and degrade misfolded periplasmic proteins or to protect proteins from being damaged [58, 65, 66].
Figure 1.

Domain architecture of HtrA, secretion routes of the protease, and involvement in virulence properties by C. jejuni. (A) Representation of the domain structure of characteristic HtrA family proteases. The protease domain is shown in yellow, PDZ-1 and PDZ-2 domains in red, and the three conserved amino acid residues (histidine, aspartate, and serine; HDS) at the active centre in green. A signal peptide is highlighted in light blue squares and a transmembrane (TM) domain with magenta. (B) Proposed secretion routes of C. jejuni HtrA into the extracellular space are diverse and complex. As shown in this scheme, HtrA can be presented at the bacterial cell surface (1), delivered in the supernatant as soluble protein (2), or shed in the form of outer membrane vesicles (OMVs) (3). (C) HtrA proteases are involved in C. jejuni stress management (1), as well as cleavage of host cell factors such as E-cadherin in the adherens junctions (AJs) and possibly other factors, such as occludin in the tight junctions (TJs) (2), followed by opening of cell-to-cell junctions (3). Cleavage of junctional proteins leads to disruption of the epithelial barrier (4), paving the way for bacteria to transmigrate across the cell monolayer by a paracellular route (5) and to enter deeper tissues (6). In addition, HtrA is also involved in bacterial adhesion by a yet unknown mechanism (7), basolateral targeting of fibronectin by CadF (8), and CadF-dependent invasion of host target cells (9)
Subtle conformational shifts result in different functions of HtrA homologues in different organisms. Thus, whereas E. coli HtrA/DegP is involved in heat stress, HtrA of Gram-positive Lactococcus lactis is required for the tolerance to a variety of environmental stress conditions: HtrA-deficient mutants exhibit increased sensitivity to heat, ethanol, puromycin, and sodium chloride [67]. Similar data were obtained for Firmicute Listeria monocytogenes, with regard to heat, puromycin-induced, and additionally, oxidative stress, resulting in a reduced ability for biofilm formation when its HtrA gene was mutated [68].
Recent studies revealed a direct or indirect participation of HtrA homologues in virulence of a variety of bacterial pathogens. In Clostridium difficile, inactivation of an HtrA homolog increased virulence in a hamster model, resulting from upregulation of toxin production and reduced spore formation, so in this organism, HtrA seems to down-regulate virulence [69]. In most other pathogens, HtrA enhances virulence, e.g., in Streptococcus pneumoniae, inactivation of HtrA resulted in attenuation in a mouse model for pneumonia [70]. In H. pylori, HtrA is required for paracellular translocation across a confluent polarized cell layer, enabling the bacteria to deliver their virulence factor cytotoxin-associated gene A (CagA) to the basolateral membrane of the host cells, even though infection initiates at the apical side [51, 71–74]. For this, the serine protease activity of H. pylori HtrA cleaves proteins of tight junctions like occludin, claudin-8, and the major adherens junction protein E-cadherin of epithelial cells, allowing the pathogen to transmigrate to the basolateral side, where it can inject the effector protein CagA in an integrin-dependent fashion [51, 71–76]. The second role of HtrA of H. pylori is to assist in secretion of oncogene CagA into host cells by means of a T4SS [75–77]. Cleavage of E-cadherin by HtrA homologues is not exclusive for H. pylori, as it has also been demonstrated for enteropathogenic E. coli strains and Shigella flexneri, but not for the urogenital pathogen Neisseria gonorrhoeae [51]. It is now evident that HtrA proteins are virulence factors for a number of pathogens [54, 78, 79], to which C. jejuni can be added, as will be discussed in the next sections.
Role of C. jejuni HtrA in Regulating Intracellular Stress Responses
A homolog of the htrA gene is present in every completely sequenced C. jejuni and C. coli genome. The HtrA proteins of C. jejuni and C. coli are highly similar, and their closest phylogenetic neighbours are HtrA of H. pylori and DegQ of E. coli [38, 51] (Figure 1A). During the transfer between individual hosts, C. jejuni has to survive several stressors, including heat and oxidative stress. High temperatures and atmospheric oxygen induce protein damage that needs to be avoided or repaired. Studies revealed that C. jejuni HtrA is required for the tolerance to heat stress. HtrA is not essential for growth at the temperature range that is normal for this thermophile, as a knockout mutant lacking HtrA was able to grow similarly to wild-type at temperatures between 37 °C and 42 °C. However, already at 44 °C, the number of colonies of an HtrA deletion mutant was decreased 10—4-fold compared to its isogenic wild-type [80, 81]. The protective effect of HtrA against temperature stress is due to its chaperone function, as a mutation inactivating the proteolytic function of the protein (by replacing the catalytically active serine residue in the active center by alanine, S197A) did not have an effect on stress tolerance [82]. Similar results were obtained using the antibiotic puromycin, which increases the intracellular and periplasmic amount of misfolded proteins. When bacteria lacking HtrA were treated with puromycin, smaller and fewer colonies were formed than was observed for wild-type [80]. Proteome analysis of the ΔhtrA strain used in that study revealed an increase of ClpB and DnaK at 42 °C or higher that was dependent of HtrA; the expression levels of those stress-response factors changed little at 37 °C. The cytoplasmic chaperones ClpB and DnaK are involved in the refolding and disaggregation of denatured proteins [83, 84] and can be used as indicators for increased intracellular stress, since they are activated by the presence of unfolded proteins. The described observations lead to the suggestion that C. jejuni attempts to compensate for the missing HtrA by increasing the expression of DnaK and ClpB [80]. Only the inactivation of the HtrA-proteolytic domain, as was demonstrated with a mutant in the S197A point mutant, had the same upregulating effect on the expression of ClpB and DnaK in response to high temperatures as complete deletion of htrA [82]. This shows a requirement of the functional HtrA protease domain to upregulate ClpB and DnaK chaperons that can deal with cytosolic denatured proteins. Besides tolerance to high temperatures, C. jejuni HtrA is also important for the bacteria to survive oxidative stress. A ΔhtrA mutant showed a decreased viability under high oxygen exposure (18% O2 at temperatures up to 42°C) [80, 82]. Contrary to this, the sensitivity to oxidative stress inducers such as paraquat, cumene hydroperoxide, and H2O2 was not affected by htrA deletion [80]. Interestingly, the proteolytic activity of HtrA is essential for bacterial growth during simultaneous heat and oxidative stress: the S197A mutant could not grow at all during this double stress exposure [38, 82]. These observations identify C. jejuni HtrA as a key player in stress tolerance, increasing the bacteria's survivability under unfavourable conditions that it typically encounters during its lifecycle.
Secretion of C. jejuni HtrA into the Extracellular Space
HtrA of C. jejuni is not only a periplasmic stress-response protein, but it is also secreted into the extracellular medium [38, 51]. Surface exposition and secretion of HtrA were shown to be highly efficient in two different model strains, C. jejuni strain 81–176 and strain NCTC11168 [85] (Figure 1B). This secretion is independent of the protease activity of HtrA, as was demonstrated with the S197A mutation introduced in NCTC11168 [85]. This observation excludes the possibility of autosecretion of HtrA via a type I secretion system employed by certain hemolysins of other bacteria [86].
For a number of secreted effector proteins of C. jejuni, flagella have been shown to be involved in their extracellular transport, as mentioned above for the Cia and Fed proteins [34, 41, 87]. Although C. jejuni does not contain the genes required to build a classical T3SS, there are striking structural similarities between flagella and T3SSs, both in their architecture and in their bio-assembly [88]. Flagellar filaments are more flexible and are attached to the body with a rotating motor, while T3SS form more rigid filaments that do not rotate, but bacterial flagella can act as an injectosome to deliver effectors inside a target cell, just like T3SS do [88, 89]. Early observations had already described that the secretion of C. jejuni Cia proteins is induced during incubation with human intestinal epithelial cells, and this process is contact-dependent [90]. Proteins CiaC and CiaD may be secreted in a similar manner [36, 37]. Secretion of Cia proteins was further shown to be induced by the presence of foetal calf serum (FCS) in the culture medium of C. jejuni [87]. In view of these observations, it was assessed if the secretion of HtrA was dependent on flagella and whether it was induced by the presence of foetal calf serum. It turned out that a flagella-deficient ΔflaA/flaB and other flagellar gene mutants were still able to secrete HtrA; thus, its secretion into the extracellular space is not dependent on flagella [85]. The absence of CiaB secretion was noted for the tested mutants, confirming the observations of Konkel and colleagues [40]. The same study further identified that the secretion of HtrA was induced by the presence of foetal calf serum [85].
Various bacterial pathogens utilize shedding of outer membrane vesicles (OMVs) for the delivery of virulence factors into host cells [91], and it shows that HtrA is present in purified OMVs from H. pylori [92]. It became more likely that this could also be the case for C. jejuni, with the observation that OMVs play a role in interaction between C. jejuni and intestinal epithelial cells [93] (Figure 1B). This study presented a proteome analysis of C. jejuni OMVs, revealing a number of proteins important for pathogenesis and host immune response [93]. Indeed, it was subsequently shown that OMVs of C. jejuni strain 11168H contain HtrA, together with two other proteases encoded by Cj0511 and Cj1365c [94]. The observation that these OMVs displayed proteolytic activity that could be reduced by serine protease inhibitors further provides evidence for their role in transporting active HtrA [94]. Future studies are needed to study the molecular mechanism(s) of secretion in more detail and to identify and study additional C. jejuni factors driving this process.
HtrA Substrates and Paracellular Transmigration of C. jejuni In Vitro
HtrA has been also shown to play a role during various interactions of C. jejuni with host cells (Figure 1C). Polarized epithelial cell models are particularly valuable for the study of C. jejuni activities on cell barrier permeability, transepithelial electrical resistance (TER), mode of transmigration, and cell invasion [38, 95, 96]. Electron microscopy was applied to compare the interaction of C. jejuni with non-polarised INT-407 cells with polarized Caco-2 cells, showing that the efficiency of C. jejuni invasion of Caco-2 cells was two- to threefold less, as compared to INT-407 cells [96]. Additional studies showed that C. jejuni entered the intercellular space between two neighboring cells [93, 94]. It was therefore suggested that C. jejuni can translocate across polarized Caco-2 cell monolayers, both by passing through and between cells (Figure 1C). Remarkably, C. jejuni triggered not only its own translocation but also that of non-pathogenic E. coli [97]. Several research groups supported the paracellular pathway as a major transmigration route [35, 38, 98], whereas other groups favoured the transcellular trail [97, 99, 100]. It was further shown that various C. jejuni strains mutated in the htrA gene could no longer transmigrate across polarized cells, although the flagellar motility of the mutants was not affected [39]. The reduced transmigration properties, as well as the impaired growth at elevated temperature (44 °C) and under high oxygen conditions, could be restored by trans expression of the htrA gene [81], being in line with expectations expressed two years earlier [43]. In analogy to the catalytic activity of H. pylori HtrA, it has been shown that secreted C. jejuni HtrA can degrade extracellular host proteins, such as the cell surface adhesion protein and tumour-suppressor E-cadherin [38, 50, 51, 85, 101]. In particular, C. jejuni HtrA cleaves off the extracellular NTF (N-terminal fragment) domain of E-cadherin, thus leading to the destruction of adherence junctions and subsequent downregulation of barrier function, which enables the bacteria to transmigrate across polarized MKN-28 epithelial cells via paracellular movement [38].
In accordance to HtrA function in transmigration, expression of the protease-deficient S197A mutant leads to significantly reduced transmigration of C. jejuni across polarized epithelial cells [85]. Further investigations showed that the TER values are not dramatically reduced during C. jejuni infection, although this is typically the case with other pathogens, such as Shigella flexneri, Salmonella typhimurium, Listeria monocytogenes, or Neisseria gonorrhoeae. This indicates that permanent opening of the cell-to-cell junctions may not occur as a result of C. jejuni HtrA enzymatic activity, and therefore, there is no loss of host cell integrity during transmigration [38]. During the last years, several studies confirmed early observations that factors other than HtrA may also play an important role during the transmigration of C. jejuni across polarized epithelial cells [35]. It seems that flagella, the flagella-associated bacterial motility, and the Cia proteins are all crucial for the transmigration process [35, 38, 102]. Further indications for the paracellular route came from another study, which showed that an ΔcadF mutant, who is deficient in fibronectin binding, also transmigrated as effectively as the C. jejuni wild-type strain F38011 [98]. However, another report counteracted with the observations above by showing that a LOS-deficient ΔcstII mutant in C. jejuni GB11 featured a strong imperfection in invasion and transmigration; therefore, this study favoured the transcellular route [100]. At the moment, there is no conclusive explanation for these different observations. Thus, more studies are required to confirm the exact mechanism of C. jejuni transmigration, whereby the possibility of strain-specific differences should also be considered.
Importance of HtrA in Host Cell Adhesion and Invasion by C. jejuni In Vitro
A hallmark of C. jejuni pathogenesis is its ability to adhere to epithelial cells. The major adhesin is the 37 kDa CadF protein [25, 103–106]. CadF allows the bacteria to bind to host fibronectin, a component of the extracellular matrix, present in the basolateral but not apical surface of polarized epithlial cells [23]. Thus, C. jejuni employs a major basolateral receptor for attaching to, as well as entering into, epithelial cells. Bacterial binding to host target cells decreased up to 10 times when HtrA was deleted [107], an effect that appears more pronounced compared to those of the inactivation of other proposed adhesins, such as FlpA, CapA, or JlpA [28–32]. In line with these observations, C. jejuni HtrA does not cleave fibronectin, unlike its counterpart in H. pylori [38]. Thus, fibronectin is resistant to the proteolytic activity of C. jejuni HtrA, underlining the importance of fibronectin for adhesion and invasion of C. jejuni. However, host cell attachment was not strictly dependent on the proteolytic activity of HtrA, as S197A mutants were still able to attach at significant levels to host cells. This suggests that the chaperon part of HtrA is mostly responsible for enhanced adherence capacity of C. jejuni [107]. Not only adherence to, but also invasion into epithelial cells is affected when HtrA is inactivated [38, 81, 107]. The reduced cell adherence and invasion could also be restored by trans expression of HtrA, in the same way like the transmigration properties of the used strains [81]. Taken together, both the chaperone and protease activity of HtrA are required for optimal adherence and internalization of C. jejuni to epithelial host cells. In general, HtrA has been viewed as a stress response protein, but it seems that HtrA has also specific functions during the infection process that may be stress-independent [107, 108]. This observation is in line with an increasing notion that the chaperone activity of HtrA may be involved in folding of adhesins and other virulence factors and thus could contribute in this way to host cell binding and invasion of C. jejuni. Alternatively, C. jejuni HtrA could also bind directly to host cell surface protein(s) to act as an adhesion itself, but there are as yet no such indications in the literature [108].
Function of HtrA during C. jejuni Infection of Mice In Vivo
Most studies to unravel the virulence mechanisms of C. jejuni are restricted to in vitro models, which is why experimental in vivo data elucidating the molecular mechanisms of this pathogen are scarce. One of the reasons is that conventional mice display a pronounced colonization resistance phenotype against C. jejuni, which is caused by the host-specific composition of their intestinal microbiota [109]. However, recently it was revealed that this commensal polymicrobial barrier can be overcome by complete eradication of the murine gut microbiota [109–112]. Remarkably, mice in which the depleted microbiota had been reconstituted with human gut microbiota following faecal microbiota transplantation could be stably infected with C. jejuni [109]. Furthermore, C. jejuni infected mice displayed immunopathological key features of human campylobacteriosis that were dependent on toll-like receptor 4 (TLR-4) signalling through C. jejuni lipooligosaccharide (LOS) [109]. Subsequently, two mice models for Campylobacter infection study were developed: conventional infant wild-type mice could be infected with C. jejun that resulted in self-limiting disease [113, 114], whereas secondary abiotic IL-10-/- knockout mice in which the murine gut microbiota was eradicated following broad-spectrum antibiotic treatment resulted in lethal disease upon peroral C. jejuni wild-type infection [115]. The latter provided an excellent model to study the role of HtrA during murine infection by C. jejuni.
It turned out that HtrA has a significant effect on the outcome of infection in secondary abiotic IL-10-/- mice. Six days following infection with either C. jejuni wild-type or a ΔhtrA mutant strain, both groups of animals harboured comparable loads of either strain alongside the gastrointestinal tract, but the mice infected with the ΔhtrA mutant presented with notably less severe clinical symptoms [116]. Their intestinal as well as extra-intestinal (i.e., hepatic and renal) symptoms, including systemic immunopathological sequelae of infection, were far less severe compared to wild-type infected control mice that were prone to death [116].
These intriguing results were further supported using the conventional infant mice model, which mimics human clinically manifesting acute infection less accurately. Upon being perorally infected, immediately after weaning (i.e., at the age of 3 weeks post partum), conventional infant mice exhibited acute enterocolitis that resolves within two weeks, followed by an asymptomatic carrier status with overt C. jejuni-induced intestinal and extra-intestinal immune responses [113, 114]. One week following C. jejuni ΔhtrA strain infection, these infant mice exhibited comparable intestinal bacterial loads, but they presented with less distinct colonic epithelial apoptosis as compared to C. jejuni wild-type-strain-infected counterparts; the latter was accompanied by lower pro-inflammatory cytokine levels and less expression of the matrix-degrading enzyme matrix metalloproteinase-2 (MMP-2) in the large intestine [116]. Conversely, colonic numbers of proliferating cells were increased in mice infected with C. jejuni ΔhtrA as compared to those infected with wild-type bacteria, thereby counteracting C. jejuni-induced cell damage [116]. Remarkably, the better outcome of infected mice due to htrA gene deficiency was not restricted to the intestinal tract, but could also be observed in extra-intestinal locations as well, as indicated by less pronounced inflammatory changes in the liver, kidneys, and lung of ΔhtrA versus parental-strain-infected infant mice [116]. These in vivo results clearly support the view that HtrA is a virulence factor of C. jejuni, as it is required for the penetration and spread into deeper tissue, thereby eliciting pro-inflammatory cytokines and local host cell apoptosis.
Other Proteases Identified in C. jejuni
While C. jejuni only encodes one homolog of HtrA, the bacteria produce other proteases that may also have fundamental functions in gastrointestinal colonization and infection. The specific lifestyle and amino acid-dependent metabolism of C. jejuni are similar to those of commensal gut bacteria, but differ significantly from those of other gastrointestinal pathogens. In contrast to the most frequent enteritis-inducing bacteria in the Enterobacteriaceae family, which use sugar substrates to fuel their requirements for energy and carbohydrate structures, C. jejuni depends on the catabolization of oligopeptides and amino acids released by proteases from proteins derived from diet, commensal microbiota, and the host [117]. Thus, proteases play an exceptional role in feeding C. jejuni with essential amino acids, which therefore become of extraordinary importance to maintain the virulence properties. Because of the key role of proteases in the establishment and multiplication in the gastrointestinal lumen of humans and other warm-blooded vertebrates, earlier scientific investigations have focused on the use of a single amino acid insertion into the highly conserved FtsH protease homolog of C. jejuni, which bears a specific molecular signature present in the Campylobacterales subgroup of the epsilon proteobacteria [118]. Recently, more than 45 peptidase-related proteins were identified by in silico analysis of the C. jejuni NCTC11168 genome [119]. A more detailed experimental analysis revealed that the Cj0511 serine peptidase, which was shown to be present in C. jejuni OMVs in conjunction with the HtrA and Cj1365c proteases [94], is essential for chicken colonization. The findings that OMVs produced in the presence of the bile salt taurocholic acid exerted elevated proteolytic activity and were found to be required for C. jejuni invasion and transmigration in vitro underlined the functions of the secreted proteases in C. jejuni virulence and intestinal pathogenesis [120]. Taken together, all these findings provided the first evidence that the other proteases of C. jejuni might represent excellent targets for antibacterial therapy and the protection of lifestock from C. jejuni colonization. This was further confirmed by the observations that C. jejuni mutants deficient in the zinc metalloendopeptidase PepF, the putative family C26 endopeptidase CJJ81176_1416, or the carboxyl-terminal protease CtpA resulted in a severe reduction in the ability of C. jejuni to colonize the intestines of mice [121]. Finally, a recent investigation on feed additives in chicken revealed significantly higher numbers of C. jejuni in broiler chickens which received a protease enriched diet [122].
Concluding Remarks
Campylobacter jejuni is one of the most important zoonotic pathogens and leading cause of bacterial acute gastroenteritis worldwide and of potentially more severe diseases, such as reactive arthritis or Guillain–Barré syndrome. The pathogen exhibits varying pathogenicity properties and secretes a variety of virulence-associated proteins [1–4, 16, 17, 33, 123–125]. Crossing the intestinal epithelial barrier of the host and cellular invasion by C. jejuni are described as the primary reasons of gut tissue damage in humans. The serine protease HtrA of C. jejuni is efficiently secreted into the culture supernatant, although the exact mechanism of the secretion remains to be elucidated. In addition to its function to increase the stress resistance, HtrA has been identified as a novel secreted virulence factor. By means of its proteolytic activity, the protein opens cell-to-cell junctions by cleaving E-cadherin and probably other host factors such as occludin (Figure 1C). This enables C. jejuni to enter underlying tissues, such as the lamina propria, from where it can invade the bloodstream and possibly reach distinct organs, such as the spleen, liver, or mesenteric lymph nodes. Various models exist to explain how the pathogen can trigger its own transmigration across polarized intestinal epithelial cells in vitro. We favour the paracellular transmigration mechanism, involving bacterial factors, such as flagellum and serine protease HtrA.
The ongoing spread of antibiotic resistances has become an increasing concern, both for gastrointestinal and other bacterial pathogens. The development of novel antibiotic substances has dramatically reduced, and drug resistances are becoming a priority in human medicine worldwide. Facing this new hazard, alternative treatments are urgently required. The discovery of HtrA as a novel class of bacterial virulence factors, including C. jejuni and other pathogens, suggests that secreted HtrA represents a very attractive new anti-bacterial target [53, 54, 78, 79, 126–129].
One option could be the specific inhibition of extracellular HtrA by compounds that do not need to enter the bacteria in order to be effective. This strategy has the advantage that such compounds would not affect colonization per se, limiting the selection pressure for resistance, either in the pathogen or in endogenous commensals. While many of the current antibiotics also affect commensal bacteria, the search for pathogen-selective HtrA inhibitors represents a very encouraging drug discovery strategy. Taken together, targeting of HtrA protease may represent an inspiring new option to elaborate new therapies for gastrointestinal diseases, but this requires more research. Thus, future studies on HtrA proteases will become a rewarding topic in the field.
Footnotes
Funding Sources
This work is supported by the German Science Foundation (DFG) to MB (project BO4724/1-1), MMH (HE3040/3-1), and NT (project TE776/3-1), as well as from the German Federal Ministries of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter to SBE/MMH (IP7/01KI1725D) and to SBA (IP9/01KI1725E).
Authors’ Contributions
All authors contributed to the writing of this review.
Conflicts of Interest
The authors declare that they have no conflict of interest.
References
- 1.Nachamkin I, Szymanski CM, Blaser MJ. Campylobacter. Washington (DC): ASM Press; 2008. [Google Scholar]
- 2.Dasti JI, Tareena AM, Lugerta R, Zautnera AE, Groß U. Campylobacter jejuni: a brief overview on pathogenicity- associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010;300:205–11. [DOI] [PubMed] [Google Scholar]
- 3.Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, et al. World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med. 2015;12:e1001923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Forsythe SJ. Food poisoning microorganisms. In: The Microbiology of Safe Food. Forsythe SJ, editor. Abingdon: Blackwell Science Publishers; 2000:87–148. [Google Scholar]
- 5.World Health Organization. Global burden of disease (GBD) 2002 estimates. WHO 2008; Geneva, Switzerland: Available from: http://www.who.int/topics/global_burden_of_disease/en/. [Google Scholar]
- 6.Robert Koch Institute (RKI). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2016. Berlin, Germany; 2016. [Google Scholar]
- 7.Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, et al. Food-borne diseases — the challenges of 20 years ago still persist while new ones continue to emerge. Int J Food Microbiol. 2010;139:S3–15. Erratum in: Int. J. Food. Microbiol. 2011;145:493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Powell MR. Trends in Reported Foodborne Illness in the United States; 1996–2013. Risk Anal. 2016;6:1589–98. [DOI] [PubMed] [Google Scholar]
- 9.Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev. 2015;28:687–720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Backert S, Tegtmeyer N, Ó Cróinín T, Boehm M, Heimesaat MM. Human campylobacteriosis. In: Campylobacter — Features, Detection, and Prevention of Foodborne Disease. Klein G, editor. London: Elsevier, Academic Press; 2017:1–25. [Google Scholar]
- 11.Lee MD, Newell DG. Campylobacter in poulry: filling an ecological niche. Avian Dis. 2006;50:1–9. [DOI] [PubMed] [Google Scholar]
- 12.Friedmann CR, Neimann J, Wegener HC, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Campylobacter. Nachamkin I, Blaser MJ, editors. Washington, DC: ASM Press; 2000:121–38. [Google Scholar]
- 13.Swart AN, Tomasi M, Kretzschmar M, Havelaar AH, Diekmann O. The protective effects of temporary immunity under imposed infection pressure. Epidemics. 2012;4:43–7. [DOI] [PubMed] [Google Scholar]
- 14.Skirrow MB, Blaser MJ. Clinical aspects of Campylobacter infection. In: Campylobacter. Nachamkin I, Blaser MJ, editors. Washington, DC: ASM Press; 2000:69–89. [Google Scholar]
- 15.Kist M, Bereswill S. Campylobacter jejuni. Contrib Microbiol. 2001;8:150–65. [DOI] [PubMed] [Google Scholar]
- 16.van Putten JP, van Alphen LB, Wösten MM, de Zoete MR. Molecular mechanisms of Campylobacter infection. Curr Top Microbiol Immunol. 2009; 337:197–229. [DOI] [PubMed] [Google Scholar]
- 17.Oyarzabal OA, Backert S. Microbial. Food Safety. Springer, New York; 2011. [Google Scholar]
- 18.Talukder RK, Sutradhar SR, Rahman KM, Uddin MJ, Akhter H. Guillian-Barré syndrome. Mymensingh Med J. 2011;20:748–56. [PubMed] [Google Scholar]
- 19.Wakerley BR, Uncini A, Yuki N. GBS Classification Group. Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. Nat Rev Neurol. 2014;10:537–44. [DOI] [PubMed] [Google Scholar]
- 20.Wassenaar TM, Blaser MJ. Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect. 1999;1:1023–33. [DOI] [PubMed] [Google Scholar]
- 21.Gölz G, Sharbati S, Backert S, Alter T. Quorum sensing dependent phenotypes and their molecular mechanisms in Campylobacterales. Eur J Microbiol Immunol. 2012;2:50–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kist M. Lebensmittelbedingte Infektionen durch Campylobacterales. Bundesgesundheitsbl. 2002;45:497–506. [Google Scholar]
- 23.Konkel ME, Garvis SD, Tipton S, Anderson DE, Cieplak W., Jr. Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter jejuni. Mol Microbiol. 1997;24:953–63. [DOI] [PubMed] [Google Scholar]
- 24.Krause-Gruszczynska M, Rohde M, Hartig R, Genth H, Schmidt G, Keo T, Koenig W, Miller WG, Konkel ME, Backert S. Role of the small Rho GTPases Rac1 and Cdc42 in host cell invasion of Campylobacter jejuni. Cell Microbiol. 2007;9:2431–44. [DOI] [PubMed] [Google Scholar]
- 25.Moser I, Schroeder W, Salnikow J. Campylobacter jejuni major outer membrane protein and a 59-kDa protein are involved in binding to fibronectin and INT 407 cell membranes. FEMS Microbiol Lett. 1997;157:233–8. [DOI] [PubMed] [Google Scholar]
- 26.Pei Z, Burucoa C, Grignon B, Baqar S, Huang XZ, Kopecko DJ, et al. Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun. 1998;66:938–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kelle K, Pages JM, Bolla JM. A putative adhesin gene cloned from Campylobacter jejuni. Res Microbiol. 1998;149:723–33. [DOI] [PubMed] [Google Scholar]
- 28.Jin S, Joe A, Lynett J, Hani EK, Sherman P, Chan VL. JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. Mol Microbiol. 2001;39:1225–36. [DOI] [PubMed] [Google Scholar]
- 29.Jin S, Song YC, Emili A, Sherman PM, Chan VL. JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90 alpha and triggers signaling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells. Cell Microbiol. 2003;5:165–74. [DOI] [PubMed] [Google Scholar]
- 30.Ashgar SS, Oldfield NJ, Wooldridge KG, Jones MA, Irving GJ, Turner DP, et al. CapA, an autotransporter protein of Campylobacter jejuni, mediates association with human epithelial cells and colonization of the chicken gut. J Bacteriol. 2007;189:1856–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Konkel ME, Larson CL, Flanagan RC. Campylobacter jejuni FlpA binds fibronectin and is required for maximal host cell adherence. J. Bacteriol. 2010;192:68–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Euker TP, Konkel ME. The cooperative action of bacterial fibronectinbinding proteins and secreted proteins promote maximal Campylobacter jejuni invasion of host cells by stimulating membrane ruffling. Cell Microbiol. 2012;14:226–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ó Cróinín T, Backert S. Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Front Cell Infect Microbiol. 2012;2:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wassenaar TM, Bleumink-Pluym NM, van der Zeijst BAM. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J. 1991;10:2055–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Grant CCR, Konkel ME, Cieplak W., Jr., Tompkins LS. Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect Immun. 1993;61:1764–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Neal-McKinney JM, Konkel ME. The Campylobacter jejuni CiaC virulence protein is secreted from the flagellum and delivered to the cytosol of host cells. Front Cell Infect Microbiol. 2012;2:31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Samuelson DR, Eucker TP, Bell JA, Dybas L, Mansfield LS, Konkel ME. The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease. Cell Commun Signal. 2013;11:79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Boehm M, Hoy B, Rohde M, Tegtmeyer N, Bæk KT, Oyarzabal OA, et al. Rapid paracellular transmigration of Campylobacter jejuni across polarized epithelial cells without affecting TER: role of proteolytic-active HtrA cleaving E-cadherin but not fibronectin. Gut Pathog. 2012;4:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Konkel ME, Klena JD, Rivera-Amill V, Monteville MR, Biswas D, Raphael B, et al. Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. J Bacteriol. 2004;186:3296–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Konkel ME, Kim BJ, Rivera-Amill V, Garvis SG. Bacterial secreted proteins are required for the internalization of Campylobacter jejuni into cultured mammalian cells. Mol Microbiol. 1999;32:691–701. [DOI] [PubMed] [Google Scholar]
- 41.Barrero-Tobon AM, Hendrixson DR. Identification and analysis of flagellar coexpressed determinants (Feds) of Campylobacter jejuni involved in colonization. Mol Microbiol. 2012;84:352–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Barrero-Tobon AM, Hendrixson DR. Flagellar biosynthesis exerts temporal regulation of secretion of specific Campylobacter jejuni colonization and virulence determinants. Mol Microbiol. 2014;93:957–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Backert S, Boehm M, Wessler S, Tegtmeyer N. Transmigration route of Campylobacter jejuni across polarized intestinal epithelial cells: paracellular, transcellular or both? Cell Commun Signal. 2013;11:72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Clausen T, Southan C, Ehrmann M. The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell. 2002;10:443–55. [DOI] [PubMed] [Google Scholar]
- 45.Lipinska B, Fayet O, Baird L, Georgopoulos C. Identification, characterization, and mapping of the Escherichia coli HtrA gene, whose product is essential for bacterial growth only at elevated temperatures. J Bacteriol. 1989;171:1574–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Strauch KL, Johnson K, Beckwith J. Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature. J Bacteriol. 1989;171:2689–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Waller PR, Sauer RT. Characterization of degQ and degS, Escherichia coli genes encoding homologs of the DegP protease. J Bacteriol. 1996;178:1146–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kolmar H, Waller PR, Sauer RT. The DegP and DegQ periplasmic endoproteases of Escherichia coli: specificity for cleavage sites and substrate conformation. J Bacteriol. 1996;178:5925–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Mo E, Peters SE, Willers C, Maskell DJ, Charles IG. Single, double and triple mutants of Salmonella enterica serovar typhimurium DegP (HtrA), DegQ (HhoA) and DegS (HhoB) have diverse phenotypes on exposure to elevated temperature and their growth in vivo is attenuated to different extents. Microb Pathog. 2006;41:147–82. [DOI] [PubMed] [Google Scholar]
- 50.Abfalter CM, Schubert M, Götz C, Schmidt TP, Posselt G, Wessler S. HtrA-mediated E-cadherin cleavage is limited to DegP and DegQ homologs expressed by gram-negative pathogens. Cell Commun Signal. 2016;14:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hoy B, Geppert T, Boehm M, Reisen F, Plattner P, Gadermaier G, et al. Distinct roles of secreted HtrA proteases from Gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem. 2012;287:10115–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Clausen T, Kaiser M, Huber R, Ehrmann M. HTRA proteases: regulated proteolysis in protein quality control. Nat Rev Mol Cell Biol. 2011;12:152–62. [DOI] [PubMed] [Google Scholar]
- 53.Wessler S, Schneider G, Backert S. Bacterial serine protease HtrA as a promising new target for antimicrobial therapy? Cell Commun Signal. 2017;15:4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Backert S, Bernegger S, Skórko-Glonek J, Wessler S. Extracellular HtrA serine proteases: an emerging new strategy in bacterial pathogenesis. Cell Microbiol. 2018;e12845. [DOI] [PubMed] [Google Scholar]
- 55.Page MJ, Di Cera E. Evolution of peptidase diversity. J Biol Chem. 2008;283:30010–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Merdanovic M, Clausen T, Kaiser M, Huber R, Ehrmann M. Protein quality control in the bacterial periplasm. Annu Rev Microbiol. 2011;65:149–68. [DOI] [PubMed] [Google Scholar]
- 57.Kim DY, Kwon E, Shin YK, Kweon DH, Kim KK. The mechanism of temperature-induced bacterial HtrA activation. J Mol Biol. 2008;377:410–20. [DOI] [PubMed] [Google Scholar]
- 58.Krojer T, Sawa J, Schafer E, Saibil HR, Ehrmann M, Clausen T. Structural basis for the regulated protease and chaperone function of DegP. Nature 2008;453:885–90. [DOI] [PubMed] [Google Scholar]
- 59.Jiang J, Zhang X, Chen Y, Wu Y, Zhou ZH, Chang Z, et al. Activation of DegP chaperone-protease via formation of large cage-like oligomers upon binding to substrate proteins. Proc Natl Acad Sci USA. 2008;105:11939–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Schubert A, Wrase R, Hilgenfeld R, Hansen G. Structures of DegQ from Legionella pneumophila Define Distinct ON and OFF States. J Mol Biol. 2015;427:2840–51. [DOI] [PubMed] [Google Scholar]
- 61.Albrecht N, Tegtmeyer N, Sticht H, Skórko-Glonek J, Backert S. Aminoterminal processing of Helicobacter pylori serine protease HtrA: role in oligomerization and activity regulation. Front Microbiol. 2018;9:642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Rawlings ND, Barrett AJ. Families of serine peptidases. Methods Enzymol. 1994;244:19–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Levchenko I, Smith CK, Walsh NP, Sauer RT, Baker TA. PDZ-like domains mediate binding specificity in the Clp/Hsp100 family of chaperones and protease regulatory subunits. Cell. 1997;91:939–47. [DOI] [PubMed] [Google Scholar]
- 64.Krojer T, Garrido-Franco M, Huber R, Ehrmann M, Clausen T. Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine. Nature. 2002;416:455–9. [DOI] [PubMed] [Google Scholar]
- 65.Singh N, Kuppili RR, Bose K. The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases. Arch Biochem Biophys. 2011;516:85–96. [DOI] [PubMed] [Google Scholar]
- 66.Krojer T, Sawa J, Huber R, Clausen T. HtrA proteases have a conserved activation mechanism that can be triggered by distinct molecular cues. Nat Struct Mol Biol. 2010;17:844–52 [DOI] [PubMed] [Google Scholar]
- 67.Foucaud-Scheunemann C, Poquet I. HtrA is a key factor in the response to specific stress conditions in Lactococcus lactis. FEMS Microbiol Lett. 2003;224:53–9. [DOI] [PubMed] [Google Scholar]
- 68.Wilson RL, Brown LL, Kirkwood-Watts D, Warren TK, Lund SA, King DS, et al. Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulence. Infect Immun. 2006;74:765–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Bakker D, Buckley AM, de Jong A, van Winden VJ, Verhoeks JP, Kuipers OP, et al. The HtrA-like protease CD3284 modulates virulence of Clostridium difficile. Infect Immun. 2014;82:4222–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.de Stoppelaar SF, Bootsma HJ, Zomer A, Roelofs JJ, Hermans PW, van't Veer C, et al. Streptococcus pneumoniae serine protease HtrA, but not SFP or PrtA, is a major virulence factor in pneumonia. PLoS One. 2013;8:e80062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Hoy B, Löwer M, Weydig C, Carra G, Tegtmeyer N, Geppert T, et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-Cadherin to disrupt intercellular adhesion. EMBO J. 2010;11:798–804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Perna AM, Rodrigues T, Schmidt TP, Böhm M, Stutz K, Reker D, et al. Fragmented-Based De-Novo Design Reveals a Small-Molecule Inhibitor of Helicobacter pylori HtrA. Angew Chem Int Ed. 2015;54:10244–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Schmidt TP, Perna AM, Fugmann T, Böhm M, Hiss J, Haller S, et al. Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep. 2016;6:23264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Tegtmeyer N, Moodley Y, Yamaoka Y, Pernitzsch SR, Schmidt V, Rivas F, et al. Characterisation of worldwide Helicobacter pylori strains reveals genetic conservation and essentiality of serine protease HtrA. Mol Microbiol. 2016;99:925–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Tegtmeyer N, Wessler S, Necchi V, Rohde M, Harrer A, Rau TT, et al. Helicobacter pylori Employs a Unique Basolateral Type IV Secretion Mechanism for CagA Delivery. Cell Host Microbe. 2017;22:552–60 e555. [DOI] [PubMed] [Google Scholar]
- 76.Wessler S, Backert S. A novel basolateral type IV secretion model for the CagA oncoprotein of Helicobacter pylori. Microbial Cell. 2018;5:60–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Harrer A, Boehm M, Backert S, Tegtmeyer N. Overexpression of serine protease HtrA enhances disruption of adherens junctions, paracellular transmigration and type IV secretion of CagA by Helicobacter pylori. Gut pathogens. 2017;9:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Ingmer H, Brøndsted L. Proteases in bacterial pathogenesis. Res Microbiol. 2009;160:704–10. [DOI] [PubMed] [Google Scholar]
- 79.Frees D, Brøndsted L, Ingmer H. Bacterial proteases and virulence. Subcell Biochem. 2013;66:161–92. [DOI] [PubMed] [Google Scholar]
- 80.Brøndsted L, Andersen MT, Parker M, Jorgensen K, Ingmer H. The HtrA protease of Campylobacter jejuni is required for heat and oxygen tolerance and for optimal interaction with human epithelial cells. Appl Environ Microbiol. 2005;71:3205–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Boehm M, Lind J, Backert S, Tegtmeyer N. Campylobacter jejuni serine protease HtrA plays an important role in heat tolerance, oxygen resistance, host cell adhesion, invasion, and transmigration. Eur J Microbiol Immunol. 2015;5:68–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Bæk KT, Vegge CS, Skórko-Glonek J, Brøndsted L. Different contributions of HtrA protease and chaperone activities to Campylobacter jejuni stress tolerance and physiology. Appl Environ Microbiol. 2011;77:57–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Ben-Zvi AP, Goloubinoff P. Review: mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J Struct Biol. 2001;135:84–93. [DOI] [PubMed] [Google Scholar]
- 84.Mogk A, Bukau B. Molecular chaperones: structure of a protein disaggregase. Curr Biol. 2004;14:R78–80. [DOI] [PubMed] [Google Scholar]
- 85.Boehm M, Haenel I, Hoy B, Brøndsted L, Smith TG, Hoover T, et al. Extracellular secretion of protease HtrA from Campylobacter jejuni is highly efficient and independent of its protease activity and flagellum. Eur J Microbiol Immunol. 2013;3:163–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Holland IB, Peherstorfer S, Kanonenberg K, Lenders M, Reimann S, Schmitt L. Type I Protein Secretion-Deceptively Simple yet with a Wide Range of Mechanistic Variability across the Family. EcoSal Plus. 2016;7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Christensen JE, Pacheco SA, Konkel ME. Identification of a Campylobacter jejuni –secreted protein required for maximal invasion of host cells. Mol Microbiol. 2009;73:650–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Diepold A, Armitage JP. Type III secretion systems: the bacterial flagellum and the injectisome. Philos Trans R Soc Lond B Biol Sci. 2015;370:1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Young GM, Schmiel DH, Miller VL. A new pathway for the secretion of virulence factors by bacteria: the flagellar export apparatus functions as a protein secretion system. Proc Natl Acad Sci USA. 1999;96:6456–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Rivera-Amill V, Konkel ME. Secretion of Campylobacter jejuni Cia proteins is contact dependent. Adv Exp Med Biol. 1999;473:225–9. [DOI] [PubMed] [Google Scholar]
- 91.Yoon H. Bacterial Outer Membrane Vesicles as a Delivery System for Virulence Regulation. J Microbiol Biotechnol. 2016;26:1343–7. [DOI] [PubMed] [Google Scholar]
- 92.Olofsson A, Vallström A, Petzold K, Tegtmeyer N, Schleucher J, Carlsson S, et al. Biochemical and functional characterization of Helicobacter pylori vesicles. Mol Microbiol. 2010;77:1539–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Elmi A, Watson E, Sandu P, Gundogdu O, Mills DC, Inglis NF, et al. Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect Immun. 2012;80:4089–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Elmi A, Nasher F, Jagatia H, Gundogdu O, Bajaj-Elliott M, Wren B, Dorrell N. Campylobacter jejuni outer membrane vesicle-associated proteolytic activity promotes bacterial invasion by mediating cleavage of intestinal epithelial cell E-cadherin and occludin. Cell Microbiol. 2016;18:561–72. [DOI] [PubMed] [Google Scholar]
- 95.Konkel ME, Corwin MD, Joens LA, Cieplak W. Factors that influence the interaction of Campylobacter jejuni with cultured mammalian cells. J Med Microbiol. 1992;37:30–7. [DOI] [PubMed] [Google Scholar]
- 96.Hu L, Tall BD, Curtis SK, Kopecko DJ. Enhanced microscopic definition of Campylobacter jejuni 81–176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells. Infect Immun. 2008;76:5294–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Kalischuk LD, Inglis GD, Buret AG. Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog. 2009;3:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Monteville MR, Konkel ME. Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. Infect Immun. 2002;70:6665–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Brás AM, Ketley JM. Transcellular translocation of Campylobacter jejuni across human polarised epithelial monolayers. FEMS Microbiol Lett. 1999;15:209–15. [DOI] [PubMed] [Google Scholar]
- 100.Louwen R, Nieuwenhuis EE, van Marrewijk L, Horst-Kreft D, de Ruiter L, Heikema AP, et al. Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures. Infect Immun. 2012;80:3307–3318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Heimesaat MM, Alutis M, Grudmann U, Fischer A, Tegtmeyer N, Böhm M, et al. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol. 2014a;4:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Wine E, Chan VL, Sherman PM. Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. Pediatr Res. 2008;64:599–604. [DOI] [PubMed] [Google Scholar]
- 103.Krause-Gruszczynska M, van Alphen LB, Oyarzabal OA, Alter T, Haenel I, Schliephake A, et al. Expression patterns and role of the CadF protein in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol Lett. 2007;274:9–16. [DOI] [PubMed] [Google Scholar]
- 104.Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, Buday L, et al. The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2. Cell Commun Signal. 2011;9:32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Boehm M, Krause-Gruszczynska M, Rohde M, Tegtmeyer N, Takahashi S, Oyarzabal OA, et al. Major host factors involved in epithelial cell invasion of Campylobacter jejuni: Role of fibronectin, integrin beta1, FAK, Tiam-1, DOCK180 in activating Rho GTPase Rac1. Front Cell Infect Microbiol. 2011;1:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Konkel ME, Gray SA, Kim BJ, Garvis SG, Yoon JJ. Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its product. Clin Microbiol. 1999;37:510–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Bæk KT, Vegge CS, Brøndsted L. HtrA chaperone activity contributes to host cell binding in Campylobacter jejuni. Gut Pathog. 2011b;3:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Konkel ME, Monteville MR, Rivera-Amill V, Joens LA. The pathogenesis of Campylobacter jejuni-mediated enteritis. Curr Issues Intest Microbiol. 2001;2:55–71. [PubMed] [Google Scholar]
- 109.Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, et al. Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011;6:e20953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, et al. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One. 2012;7:e35988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Groß U, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol. 2013;2013:526860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Heimesaat MM, Bereswill S. Murine infection models for the investigation of Campylobacter jejuni–host interactions and pathogenicity. Berl Münch Tierärztl Wochenschr. 2015;128:98–103. [PubMed] [Google Scholar]
- 113.Haag LM, Fischer A, Otto B, Grundmann U, Kühl AA, Göbel UB, et al. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol. 2012;2:2–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Heimesaat MM, Haag LM, Fischer A, Otto B, Kühl AA, Göbel UB, et al. Survey of extra-intestinal immune responses in asymtomatic long-term Campylobacter jejuni infected mice. Eur J Microbiol Immunol. 2013;3:174–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Haag LM, Fischer A, Otto B, Plickert R, Göbel UB, Bereswill S, et al. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via TLR-2 and -4 signaling. PLoS One. 2012;7:e40761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Heimesaat MM, Fischer A, Alutis M, Grundmann U, Boehm M, Tegtmeyer N, et al. The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during C. jejuni infection of infant mice. Gut Pathog. 2014;6:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Hofreuter D. Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni. Front Cell Infect Microbiol. 2014;4:137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Gupta RS. Molecular signatures (unique proteins and conserved indels) that are specific for the epsilon proteobacteria (Campylobacterales). BMC Genomics. 2006;7:167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Karlyshev AV, Thacker G, Jones MA, Clements MO, Wren BW. Campylobacter jejuni gene cj0511 encodes a serine peptidase essential for colonisation. FEBS Open Bio. 2014;4:468–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Elmi A, Dorey A, Watson E, Jagatia H, Inglis NF, Gundogdu O, et al. The bile salt sodium taurocholate induces Campylobacter jejuni outer membrane vesicle production and increases OMV-associated proteolytic activity. Cell Microbiol. 2018;20. [DOI] [PubMed] [Google Scholar]
- 121.Gao B, Vorwerk H, Huber C, Lara-Tejero M, Mohr J, Goodman AL, et al. Metabolic and fitness determinants for in vitro growth and intestinal colonization of the bacterial pathogen Campylobacter jejuni. PLoS Biol. 2017;15:e2001390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Yin D, Yin X, Wang X, Lei Z, Wang M, Guo Y, et al. Supplementation of amylase combined with glucoamylase or protease changes intestinal microbiota diversity and benefits for broilers fed a diet of newly harvested com. J Anim Sci Biotechnol. 2018;9:24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Tegtmeyer N, Rohde M, Backert S. Clinical presentations and pathogenicity mechanisms of bacterial foodborne diseases. In Oyarzabal OA, Backert S, editors. Microbial Food Safety. New York: Springer; 2012. p. 13–32. [Google Scholar]
- 124.Oyarzabal OA, Backert S. Varying pathogenicity of Campylobacter jejuni isolates. In Gurtler JB, Doyle MP, Kornack JL, editors. Foodborne Pathogens: Virulence Factors and Host Susceptibility. New York: Springer; 2016. p. 41–60. [Google Scholar]
- 125.Oyarzabal OA, Backert S. Control of Campylobacter spp. in Commercial Poultry Production. In Fonseca BB, Rossi DA, Fernandez H, editors. Campylobacter spp. and related organisms in poultry: relationship pathogen host, diagnosis and epidemiology, New York: Springer; 2016. p. 137–50. [Google Scholar]
- 126.Backert S, Schmidt TP, Harrer A, Wessler S. Exploiting the Gastric Epithelial Barrier: Helicobacter pylori's Attack on Tight and Adherens Junctions. Curr Top Microbiol Immunol. 2017;400:195–226. [DOI] [PubMed] [Google Scholar]
- 127.Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol. 2008;16:397–405. [DOI] [PubMed] [Google Scholar]
- 128.Posselt G, Backert S, Wessler S. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal. 2013;11:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Skórko-Glonek J, Figaj D, Zarzecka U, Przepiora T, Renke J, Lipinska B. The Extracellular Bacterial HtrA Proteins as Potential Therapeutic Targets and Vaccine Candidates. Curr Med Chem. 2017;24:2174–204. [DOI] [PubMed] [Google Scholar]
